Mircean Cristian, Tabus Ioan, Kobayashi Tohru, Yamaguchi Motoko, Shiku Hiroshi, Shmulevich Ilya, Zhang Wei
Institute of Signal Processing, Tampere University of Technology, FIN-33101 Tampere, Finland.
Int J Oncol. 2004 Mar;24(3):497-504.
Recent clinicopathological studies identified a unique subgroup of diffuse large B-cell lymphoma (DLBCL) that expresses CD5 on the cell surface. This 'de novo CD5+ DLBCL' comprises 10% of all DLBCL and has a poorer prognosis than CD5- DLBCL. Comparison of gene expression profiles between de novo CD5+ DLBCLs and CD5- DLBCLs shows that de novo CD5+ DLBCL expresses high levels of integrin beta1 in tumor cells and CD36 in the vascular cells. On the other hand, comparison between mantle cell lymphomas (MCLs) and DLBCLs expectedly identified cyclin D1 as a top feature gene. To gain insight into the molecular pathway differences among the three types of lymphoma, we evaluated the functional categories of groups of genes important for the discrimination among the three groups. We first selected 280 (from 2,142) genes, according to their individual discriminatory power. We then used the gene-shaving clustering algorithm and identified 22 clusters of genes. Of the 22 clusters, six were highly correlated with the class labels of the patients and the top three clusters accounted for the major difference among the three lymphoma subtypes. A multidimensional scaling (MDS) analysis using the average genes from the top three clusters separated the three lymphoma subtypes quite well. The functions of the genes in the top three gene clusters showed a significant enrichment of metabolism and signal transduction. To further examine whether genes of particular functions reflect more faithfully the difference between the subtypes of lymphomas, we separated the 280 informative genes into six different functional groups and performed MDS analysis using each of the gene groups. Four of the gene-function groups (metabolism, signal transduction pathway, transcriptional factors, cell adhesion and migration), separated the three lymphoma subtypes well, whereas apoptosis genes and cell cycle genes did not result in good separation.
最近的临床病理研究发现了弥漫性大B细胞淋巴瘤(DLBCL)的一个独特亚组,其细胞表面表达CD5。这种“原发性CD5+ DLBCL”占所有DLBCL的10%,预后比CD5- DLBCL更差。原发性CD5+ DLBCL与CD5- DLBCL之间基因表达谱的比较表明,原发性CD5+ DLBCL在肿瘤细胞中高表达整合素β1,在血管细胞中高表达CD36。另一方面,套细胞淋巴瘤(MCL)与DLBCL之间的比较不出所料地将细胞周期蛋白D1确定为首要特征基因。为了深入了解这三种淋巴瘤之间的分子途径差异,我们评估了对这三组淋巴瘤具有鉴别作用的重要基因群的功能类别。我们首先根据280个(从2142个中筛选)基因各自的鉴别能力进行选择。然后我们使用基因剔除聚类算法,确定了22个基因簇。在这22个基因簇中,有6个与患者的分类标签高度相关,前三个基因簇构成了三种淋巴瘤亚型之间的主要差异。使用前三个基因簇的平均基因进行的多维标度(MDS)分析能够很好地区分这三种淋巴瘤亚型。前三个基因簇中的基因功能显示出代谢和信号转导的显著富集。为了进一步研究特定功能的基因是否更忠实地反映淋巴瘤亚型之间的差异,我们将280个信息基因分为六个不同的功能组,并使用每个基因组进行MDS分析。其中四个基因功能组(代谢、信号转导途径、转录因子、细胞黏附和迁移)能够很好地区分三种淋巴瘤亚型,而凋亡基因和细胞周期基因则不能实现良好的区分。